BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22648268)

  • 1. An update on the genetics of pheochromocytoma.
    Karasek D; Shah U; Frysak Z; Stratakis C; Pacak K
    J Hum Hypertens; 2013 Mar; 27(3):141-7. PubMed ID: 22648268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing for pheochromocytoma.
    Karasek D; Frysak Z; Pacak K
    Curr Hypertens Rep; 2010 Dec; 12(6):456-64. PubMed ID: 20938758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
    Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
    Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.
    Havekes B; van der Klaauw AA; Weiss MM; Jansen JC; van der Mey AG; Vriends AH; Bonsing BA; Romijn JA; Corssmit EP
    Endocr Relat Cancer; 2009 Jun; 16(2):527-36. PubMed ID: 19289533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytoma and abdominal paraganglioma.
    Renard J; Clerici T; Licker M; Triponez F
    J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Paragangliomas and Pheochromocytomas.
    Lam AK
    Turk Patoloji Derg; 2015; 31 Suppl 1():105-12. PubMed ID: 26177321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytomas and secreting paragangliomas.
    Plouin PF; Gimenez-Roqueplo AP
    Orphanet J Rare Dis; 2006 Dec; 1():49. PubMed ID: 17156452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.
    Vicha A; Musil Z; Pacak K
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):186-91. PubMed ID: 23481210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
    Elder EE; Elder G; Larsson C
    J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic diagnosis of phaeochromocytomas and paragangliomas].
    Cardot-Bauters C; Ainaouï M; Coppin L; Pigny P
    Presse Med; 2014 Apr; 43(4 Pt 1):460-7. PubMed ID: 24612707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
    Moraitis AG; Martucci VL; Pacak K
    Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma and paraganglioma.
    Pacak K; Wimalawansa SJ
    Endocr Pract; 2015 Apr; 21(4):406-12. PubMed ID: 25716634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
    Jochmanová I; Lazúrová I
    Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients.
    Yamazaki Y; Gao X; Pecori A; Nakamura Y; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Sasano H
    Front Endocrinol (Lausanne); 2020; 11():587769. PubMed ID: 33193100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.
    Mete O; Tischler AS; de Krijger R; McNicol AM; Eisenhofer G; Pacak K; Ezzat S; Asa SL
    Arch Pathol Lab Med; 2014 Feb; 138(2):182-8. PubMed ID: 24476517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.